Skip to main content
. 2022 Apr 6;7(2):100447. doi: 10.1016/j.esmoop.2022.100447

Figure 1.

Figure 1

Treatment scheme in the 20 patients of the primary phase (upper diagram) and 30 patients of the expansion phase (lower diagram).

D, Day of cycle; EGFR, epidermal growth factor receptor; MT, monotherapy; Q2W, every 2 weeks; W, week.